The Role of Interleukins in HBV Infection: A Narrative Review
Konstantinos Dimitriadis, Stamatia Katelani, Maria Pappa, George E. Fragkoulis, Theodoros Androutsakos · 2023
Read The Role of Interleukins in HBV Infection: A Narrative Review by Konstantinos Dimitriadis, Stamatia Katelani, Maria Pappa, George E. Fragkoulis, Theodoros Androutsakos (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10744424.txt.
Description
Konstantinos Dimitriadis and co-authors review what messenger proteins called interleukins do in hepatitis B infection, in a 2023 narrative review. The virus is a leading cause of chronic liver disease and liver cancer worldwide. Immune signals decide whether the virus is suppressed or persists, and drugs that block interleukins for other diseases can wake a sleeping infection, which makes the map clinically urgent.
The review sorts the family by effect. Several inflammation-driving members help suppress the virus, while the calming members IL-10, IL-23, and IL-35 seem to help it copy itself. IL-17 tracks with liver injury. A few members have been tried as treatments with mixed results, and IL-22 remains murky, possibly both copying helper and damage driver. The authors offer the map to clinicians weighing immune therapy in patients with past or present hepatitis B.
Catalog record
| CREATOR | Konstantinos Dimitriadis, Stamatia Katelani, Maria Pappa, George E. Fragkoulis, Theodoros Androutsakos |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |